In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.

A man who says he got 'Ozempic penis' from the weight loss drug Wegovy has opened up on how his sex life has been going ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...

Eli Lilly’s weight-loss pill, orforglipron, shows promising results in trials, offering a needle-free alternative to injectables like Ozempic and Mounjaro. In a major study, people who took the drug ...

Eli Lilly, the manufacturer of a new weight-loss pill (an alternative to popular weight-loss jabs), says the drug could be ...

Britain's pharmacy regulator warned it had been forced to step in, to 'investigate concerns' that prescription drugs had been ...

A weight loss pill called orforglipron has had some successful results from the human trial stage, so when could we see it on the NHS?

AN influencer says she’s been trolled for still eating her favourite pizza, smothered in chips, cheese and curry sauce.

A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Lisa Bernett lost more than 10 stone without jabs or surgery. She shares how she transformed her eating habits and fitness ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...